|If prior history of neonatal lupus: Weekly fetal echocardiography in weeks 16–26 [68]|Conditional| |
|Medication|Paternal medication| |
|If planning to father a child: Discuss medication use including CYC|GPS| |
|Discontinue CYC and thalidomide [133, 139]|Strong/conditional| |
|Continue HCQ, AZA, infliximab, etanercept, adalimumab, golimumab, certolizumab, colchicine [90, 115, 143, 146, 149, 152, 155, 97]|Strong| |
|Continue leflunomide, MMF, NSAIDs, sulfasalazine, cyclosporine, tacrolimus, anakinra, rituximab [108, 119, 85, 94, 126, 130, 159, 163]|Conditional| |
|If planning pregnancy: Discuss medication use including CYC|GPS| |
|If pregnant and exposed to teratogenic medications: Discontinue immediately, pursue counseling|GPS| |
|Discontinue NSAIDs if difficulty conceiving [86]|Conditional| |
|Avoid NSAIDs in third trimester [87]|Strong| |
|Use nonselective rather than COX-2–specific NSAIDs [88]|Conditional| |